News tagged with celebrex

Pfizer stock trades halted over drug patent ruling

A U.S. court on Wednesday invalidated the key patent for one of Pfizer's most lucrative medicines, potentially opening the door for cheaper generic versions 18 months sooner than expected and cutting into the drugmaker's ...

Mar 12, 2014
popularity0 comments 0

Pfizer 2Q mixed, maintains 2013 outlook

Pfizer's second-quarter net income more than quadrupled, helped by the sale of its animal health business. The world's second-largest drugmaker beat Wall Street's earnings expectations, though revenue continued to decline ...

Jul 30, 2013
popularity0 comments 0

Pfizer Q1 profit up, but drugmaker cuts outlook

Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's expectations, and ...

Apr 30, 2013
popularity0 comments 0

Discovering new uses for old drugs

With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different ...

Aug 01, 2012
popularity0 comments 0

Celecoxib

Celecoxib INN ( /sɛlɨˈkɒksɪb/) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. It is known under the brand name Celebrex or Celebra for arthritis and Onsenal for polyps. Celecoxib is available by prescription in capsule form.

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed